Sound Wave Innovation is developing a therapeutic platform built around Low-Intensity Pulsed Ultrasound (LIPUS) aimed at treating early-stage Alzheimer’s disease with its flagship LIPUS-Brain device. Exploratory clinical studies completed in 2022 reported a strong safety profile and suggested potential efficacy for patients with early-stage Alzheimer’s and mild cognitive impairment. In 2022 the LIPUS-Brain system was designated by Japan’s Ministry of Health, Labour and Welfare as the country’s first “Breakthrough Medical Device” for Alzheimer’s treatment. The company has a strategic manufacturing and commercialization partnership with Sumitomo Heavy Industries, which will oversee manufacturing and distribution while Sound Wave Innovation continues clinical development and IP licensing. Sound Wave Innovation raised about $17 million in a Series C to fund completion of a pivotal confirmatory trial expected to finish by the end of 2026. After the trial the company and its partners are targeting regulatory approval.

Total raised

$17M

Funding rounds

1

Latest round

Series C

Latest activity

May 2026